High Court directs Bihar government to reply on scarcity of medicines in three weeks

Published On 2019-08-28 04:01 GMT   |   Update On 2019-08-28 04:01 GMT

Bihar: Patna High Court today directed Bihar government to reply in three weeks on the issue of scarcity of medicines at government hospitals.After hearing arguments on public interest litigation filed by a social worker Vikas Chandra alias Guddu Baba, a division bench of Patna High Court headed by Justice S Pandey directed the state government to reply within three weeks on the issue of...

Login or Register to read the full article

Bihar: Patna High Court today directed Bihar government to reply in three weeks on the issue of scarcity of medicines at government hospitals.


After hearing arguments on public interest litigation filed by a social worker Vikas Chandra alias Guddu Baba, a division bench of Patna High Court headed by Justice S Pandey directed the state government to reply within three weeks on the issue of scarcity of medicines at government hospitals.


Read Also: Now, Direct Campus placements from government medical colleges in Bihar


The petitioner`s counsel said that there was a huge scarcity of medicines at the government hospitals. Patients were not able to get even general medicines at the government hospitals compelling them to purchase medicines from outside the hospitals, he added.


Read Also: Encephalitis in Bihar: Dr Harsh Vardhan finalises Site, Design of 100 bedded PICU

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News